Testicular cancer

Robert J. Motzer, Neeraj Agarwal, Clair Beard, Graeme B. Bolger, Barry Boston, Michael A. Carducci, Toni K. Choueiri, Robert A. Figlin, Mayer Fishman, Steven L. Hancock, Gary R. Hudes, Eric Jonasch, Anne Kessinger, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto PiliBruce G. Redman, Cary N. Robertson, Lawrence H. Schwartz, Joel Sheinfeld, Jue Wang

Research output: Contribution to journalReview article

79 Citations (Scopus)

Abstract

An estimated 8090 new cases of testicular cancer were diagnosed in the United States in 2008. Although relatively uncommon overall, germ cell tumors (GCTs) constitute the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure. Updates to the 2009 NCCN Guidelines include the addition of doses for single-agent carboplatin for seminoma and changes to category 1 for recommendations on radiotherapy and surveillance.

Original languageEnglish (US)
Pages (from-to)672-693
Number of pages22
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume7
Issue number6
DOIs
StatePublished - Jun 2009

Fingerprint

Testicular Neoplasms
Germ Cell and Embryonal Neoplasms
Neoplasms
Seminoma
Carboplatin
Radiotherapy
Guidelines
Drug Therapy
Incidence
Therapeutics

Keywords

  • Alpha-fetoprotein
  • Cisplatin
  • Germ cell tumors
  • Human chorionic gonadotropin
  • Lactate dehydrogenase
  • NCCN Clinical Practice Guidelines
  • Nonseminoma
  • Seminoma
  • Testicular cancer

ASJC Scopus subject areas

  • Oncology

Cite this

Motzer, R. J., Agarwal, N., Beard, C., Bolger, G. B., Boston, B., Carducci, M. A., ... Wang, J. (2009). Testicular cancer. JNCCN Journal of the National Comprehensive Cancer Network, 7(6), 672-693. https://doi.org/10.6004/jnccn.2009.0047

Testicular cancer. / Motzer, Robert J.; Agarwal, Neeraj; Beard, Clair; Bolger, Graeme B.; Boston, Barry; Carducci, Michael A.; Choueiri, Toni K.; Figlin, Robert A.; Fishman, Mayer; Hancock, Steven L.; Hudes, Gary R.; Jonasch, Eric; Kessinger, Anne; Kuzel, Timothy M.; Lange, Paul H.; Levine, Ellis G.; Margolin, Kim A.; Michaelson, M. Dror; Olencki, Thomas; Pili, Roberto; Redman, Bruce G.; Robertson, Cary N.; Schwartz, Lawrence H.; Sheinfeld, Joel; Wang, Jue.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 7, No. 6, 06.2009, p. 672-693.

Research output: Contribution to journalReview article

Motzer, RJ, Agarwal, N, Beard, C, Bolger, GB, Boston, B, Carducci, MA, Choueiri, TK, Figlin, RA, Fishman, M, Hancock, SL, Hudes, GR, Jonasch, E, Kessinger, A, Kuzel, TM, Lange, PH, Levine, EG, Margolin, KA, Michaelson, MD, Olencki, T, Pili, R, Redman, BG, Robertson, CN, Schwartz, LH, Sheinfeld, J & Wang, J 2009, 'Testicular cancer', JNCCN Journal of the National Comprehensive Cancer Network, vol. 7, no. 6, pp. 672-693. https://doi.org/10.6004/jnccn.2009.0047
Motzer RJ, Agarwal N, Beard C, Bolger GB, Boston B, Carducci MA et al. Testicular cancer. JNCCN Journal of the National Comprehensive Cancer Network. 2009 Jun;7(6):672-693. https://doi.org/10.6004/jnccn.2009.0047
Motzer, Robert J. ; Agarwal, Neeraj ; Beard, Clair ; Bolger, Graeme B. ; Boston, Barry ; Carducci, Michael A. ; Choueiri, Toni K. ; Figlin, Robert A. ; Fishman, Mayer ; Hancock, Steven L. ; Hudes, Gary R. ; Jonasch, Eric ; Kessinger, Anne ; Kuzel, Timothy M. ; Lange, Paul H. ; Levine, Ellis G. ; Margolin, Kim A. ; Michaelson, M. Dror ; Olencki, Thomas ; Pili, Roberto ; Redman, Bruce G. ; Robertson, Cary N. ; Schwartz, Lawrence H. ; Sheinfeld, Joel ; Wang, Jue. / Testicular cancer. In: JNCCN Journal of the National Comprehensive Cancer Network. 2009 ; Vol. 7, No. 6. pp. 672-693.
@article{192d582cbda24aa3966a51a8e7d50581,
title = "Testicular cancer",
abstract = "An estimated 8090 new cases of testicular cancer were diagnosed in the United States in 2008. Although relatively uncommon overall, germ cell tumors (GCTs) constitute the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90{\%} of patients diagnosed with GCTs are cured, including 70{\%} to 80{\%} of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure. Updates to the 2009 NCCN Guidelines include the addition of doses for single-agent carboplatin for seminoma and changes to category 1 for recommendations on radiotherapy and surveillance.",
keywords = "Alpha-fetoprotein, Cisplatin, Germ cell tumors, Human chorionic gonadotropin, Lactate dehydrogenase, NCCN Clinical Practice Guidelines, Nonseminoma, Seminoma, Testicular cancer",
author = "Motzer, {Robert J.} and Neeraj Agarwal and Clair Beard and Bolger, {Graeme B.} and Barry Boston and Carducci, {Michael A.} and Choueiri, {Toni K.} and Figlin, {Robert A.} and Mayer Fishman and Hancock, {Steven L.} and Hudes, {Gary R.} and Eric Jonasch and Anne Kessinger and Kuzel, {Timothy M.} and Lange, {Paul H.} and Levine, {Ellis G.} and Margolin, {Kim A.} and Michaelson, {M. Dror} and Thomas Olencki and Roberto Pili and Redman, {Bruce G.} and Robertson, {Cary N.} and Schwartz, {Lawrence H.} and Joel Sheinfeld and Jue Wang",
year = "2009",
month = "6",
doi = "10.6004/jnccn.2009.0047",
language = "English (US)",
volume = "7",
pages = "672--693",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "6",

}

TY - JOUR

T1 - Testicular cancer

AU - Motzer, Robert J.

AU - Agarwal, Neeraj

AU - Beard, Clair

AU - Bolger, Graeme B.

AU - Boston, Barry

AU - Carducci, Michael A.

AU - Choueiri, Toni K.

AU - Figlin, Robert A.

AU - Fishman, Mayer

AU - Hancock, Steven L.

AU - Hudes, Gary R.

AU - Jonasch, Eric

AU - Kessinger, Anne

AU - Kuzel, Timothy M.

AU - Lange, Paul H.

AU - Levine, Ellis G.

AU - Margolin, Kim A.

AU - Michaelson, M. Dror

AU - Olencki, Thomas

AU - Pili, Roberto

AU - Redman, Bruce G.

AU - Robertson, Cary N.

AU - Schwartz, Lawrence H.

AU - Sheinfeld, Joel

AU - Wang, Jue

PY - 2009/6

Y1 - 2009/6

N2 - An estimated 8090 new cases of testicular cancer were diagnosed in the United States in 2008. Although relatively uncommon overall, germ cell tumors (GCTs) constitute the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure. Updates to the 2009 NCCN Guidelines include the addition of doses for single-agent carboplatin for seminoma and changes to category 1 for recommendations on radiotherapy and surveillance.

AB - An estimated 8090 new cases of testicular cancer were diagnosed in the United States in 2008. Although relatively uncommon overall, germ cell tumors (GCTs) constitute the most common solid tumor in men between the ages of 15 and 34 years. The worldwide incidence of these tumors has more than doubled in the past 40 years. More than 90% of patients diagnosed with GCTs are cured, including 70% to 80% of patients with advanced tumors who are treated with chemotherapy. Standard therapy has been established at essentially all stages of management and must be closely followed to ensure the potential for cure. Updates to the 2009 NCCN Guidelines include the addition of doses for single-agent carboplatin for seminoma and changes to category 1 for recommendations on radiotherapy and surveillance.

KW - Alpha-fetoprotein

KW - Cisplatin

KW - Germ cell tumors

KW - Human chorionic gonadotropin

KW - Lactate dehydrogenase

KW - NCCN Clinical Practice Guidelines

KW - Nonseminoma

KW - Seminoma

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=67651235907&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67651235907&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2009.0047

DO - 10.6004/jnccn.2009.0047

M3 - Review article

C2 - 19555582

AN - SCOPUS:67651235907

VL - 7

SP - 672

EP - 693

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 6

ER -